Preparation, characterization and in-vivo efficacy study of glatiramer acetate (GA)-hydrogel-microparticles as novel drug delivery system for GA in RRMS

Relapsing Remitting Multiple Sclerosis is a chronic Central nervous system autoimmune disease. There is no absolute treatment for MS and the available remedies are called disease modifying therapies (DMTs). Glatiramer acetate (GA) is one of the FDA approved DMTs. Currently, injection-site problems a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadidi, Naghmeh, Pazuki, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772231/
https://www.ncbi.nlm.nih.gov/pubmed/36543898
http://dx.doi.org/10.1038/s41598-022-26640-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772231/
https://www.ncbi.nlm.nih.gov/pubmed/36543898
http://dx.doi.org/10.1038/s41598-022-26640-x

Ejemplares similares